PT2480540T - Pentahidrato de cloreto de metiltionínio e respetivas preparação e utilização farmacêutica - Google Patents
Pentahidrato de cloreto de metiltionínio e respetivas preparação e utilização farmacêuticaInfo
- Publication number
- PT2480540T PT2480540T PT107711806T PT10771180T PT2480540T PT 2480540 T PT2480540 T PT 2480540T PT 107711806 T PT107711806 T PT 107711806T PT 10771180 T PT10771180 T PT 10771180T PT 2480540 T PT2480540 T PT 2480540T
- Authority
- PT
- Portugal
- Prior art keywords
- preparation
- pharmaceutical use
- methylthioninium chloride
- chloride pentahydrate
- pentahydrate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Steroid Compounds (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24537209P | 2009-09-24 | 2009-09-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2480540T true PT2480540T (pt) | 2018-02-16 |
Family
ID=43662090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT107711806T PT2480540T (pt) | 2009-09-24 | 2010-09-23 | Pentahidrato de cloreto de metiltionínio e respetivas preparação e utilização farmacêutica |
Country Status (17)
Country | Link |
---|---|
US (1) | US8901296B2 (pt) |
EP (1) | EP2480540B1 (pt) |
JP (2) | JP5918136B2 (pt) |
KR (1) | KR101728574B1 (pt) |
CN (1) | CN102666510B (pt) |
AU (1) | AU2010299574B2 (pt) |
BR (1) | BR112012006626B8 (pt) |
CA (1) | CA2773306C (pt) |
DK (1) | DK2480540T3 (pt) |
ES (1) | ES2659091T3 (pt) |
HR (1) | HRP20180347T1 (pt) |
MX (1) | MX2012003035A (pt) |
MY (1) | MY161463A (pt) |
PL (1) | PL2480540T3 (pt) |
PT (1) | PT2480540T (pt) |
SI (1) | SI2480540T1 (pt) |
WO (1) | WO2011036561A2 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2011334679B2 (en) * | 2010-11-30 | 2016-12-15 | Wista Laboratories Ltd. | Formulations comprising methylthioninium chloride |
SG11201900228YA (en) | 2016-07-25 | 2019-02-27 | Wista Lab Ltd | Administration and dosage of diaminophenothiazines |
GB201614834D0 (en) * | 2016-09-01 | 2016-10-19 | Wista Lab Ltd | Treatment of dementia |
WO2023232764A1 (en) | 2022-05-31 | 2023-12-07 | Wista Laboratories Ltd. | Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds |
WO2024061971A1 (en) | 2022-09-21 | 2024-03-28 | Wista Laboratories Ltd. | Novel formulations and vehicles |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030119060A1 (en) * | 2001-08-10 | 2003-06-26 | Desrosiers Peter J. | Apparatuses and methods for creating and testing pre-formulations and systems for same |
PT1799662E (pt) * | 2004-09-23 | 2013-07-09 | Wista Lab Ltd | Métodos de síntese química e purificação de compostos de diaminofenotiazínio incluindo cloreto de metiltionínio (mtc) |
CN101084204B (zh) * | 2004-09-23 | 2012-12-05 | 卫思道制药有限公司 | 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法 |
EP2013191B3 (en) * | 2006-03-29 | 2019-02-27 | Wista Laboratories Ltd. | 3,7-diamino-10h-phenothiazine salts and their use |
SG10201408584UA (en) * | 2009-09-24 | 2015-02-27 | Wista Lab Ltd | Crystalline Methylthionium Chloride Hydrates |
-
2010
- 2010-09-23 CA CA2773306A patent/CA2773306C/en active Active
- 2010-09-23 PL PL10771180T patent/PL2480540T3/pl unknown
- 2010-09-23 DK DK10771180.6T patent/DK2480540T3/en active
- 2010-09-23 US US13/497,691 patent/US8901296B2/en active Active
- 2010-09-23 PT PT107711806T patent/PT2480540T/pt unknown
- 2010-09-23 EP EP10771180.6A patent/EP2480540B1/en active Active
- 2010-09-23 KR KR1020127009858A patent/KR101728574B1/ko active IP Right Grant
- 2010-09-23 BR BR112012006626A patent/BR112012006626B8/pt active IP Right Grant
- 2010-09-23 CN CN201080053177.8A patent/CN102666510B/zh active Active
- 2010-09-23 AU AU2010299574A patent/AU2010299574B2/en active Active
- 2010-09-23 MY MYPI2012001321A patent/MY161463A/en unknown
- 2010-09-23 ES ES10771180.6T patent/ES2659091T3/es active Active
- 2010-09-23 WO PCT/IB2010/002543 patent/WO2011036561A2/en active Application Filing
- 2010-09-23 SI SI201031633T patent/SI2480540T1/en unknown
- 2010-09-23 MX MX2012003035A patent/MX2012003035A/es active IP Right Grant
- 2010-09-23 JP JP2012530358A patent/JP5918136B2/ja active Active
-
2015
- 2015-11-24 JP JP2015228627A patent/JP2016074699A/ja active Pending
-
2018
- 2018-02-26 HR HRP20180347TT patent/HRP20180347T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
CN102666510B (zh) | 2016-09-14 |
KR20120099410A (ko) | 2012-09-10 |
JP2013505926A (ja) | 2013-02-21 |
WO2011036561A2 (en) | 2011-03-31 |
SI2480540T1 (en) | 2018-03-30 |
US8901296B2 (en) | 2014-12-02 |
PL2480540T3 (pl) | 2018-05-30 |
US20120289499A1 (en) | 2012-11-15 |
BR112012006626B1 (pt) | 2021-04-20 |
EP2480540B1 (en) | 2017-11-29 |
CN102666510A (zh) | 2012-09-12 |
DK2480540T3 (en) | 2018-01-22 |
AU2010299574A1 (en) | 2012-03-29 |
WO2011036561A8 (en) | 2012-04-19 |
JP2016074699A (ja) | 2016-05-12 |
CA2773306A1 (en) | 2011-03-31 |
KR101728574B1 (ko) | 2017-04-19 |
CA2773306C (en) | 2018-04-24 |
ES2659091T3 (es) | 2018-03-13 |
MX2012003035A (es) | 2012-06-12 |
MY161463A (en) | 2017-04-14 |
BR112012006626B8 (pt) | 2021-05-25 |
EP2480540A2 (en) | 2012-08-01 |
BR112012006626A2 (pt) | 2016-05-03 |
WO2011036561A3 (en) | 2011-05-19 |
HRP20180347T1 (hr) | 2018-04-06 |
JP5918136B2 (ja) | 2016-05-18 |
AU2010299574B2 (en) | 2013-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL217208A0 (en) | Novel conjugates, preparation thereof, and therapeutic use thereof | |
ZA201300685B (en) | Anticancer derivatives,preparation thereof and therapeutic use thereof | |
HK1161878A1 (en) | Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof | |
IL231386A0 (en) | Pyrazoloquinolinone derivatives, their preparation and medical use | |
IL214175A (en) | Derivatives of aminotetralin, their pharmaceutical compositions and their use | |
ZA201300957B (en) | 5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide, salts and use thereof | |
PL2655375T3 (pl) | Pochodne pirymidynonu, ich wytwarzanie i ich farmaceutyczne zastosowanie | |
HK1159108A1 (en) | Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof | |
HK1167597A1 (en) | Dodeca-2e,4e-diene amides and their use as medicaments and cosmetics -2e4e- | |
HK1151791A1 (en) | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | |
IL219888A0 (en) | Pyridine-pyridinone derivatives, preparation and therapeutic use thereof | |
IL215835A (en) | Carboxamide compounds and their use as a drug | |
IL216105A0 (en) | Non-cating salt composition, preparation process and use thereof | |
GB0920258D0 (en) | New medical agents and use thereof | |
ZA201107363B (en) | Quinazolinedione derivatives,preparation thereof and various therapeutic uses thereof | |
PL2480540T3 (pl) | Pentahydrat chlorku metylotioninowego, jego wytwarzanie i zastosowanie farmaceutyczne | |
GB0908425D0 (en) | Medical use | |
HK1164861A1 (en) | Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation thereof, and therapeutic use thereof | |
HK1164883A1 (en) | Carvedilol sulfate crystals, preparation methods and pharmaceutical use thereof | |
SI2603217T1 (sl) | Novi 6,7-disubstituirani-isokinolinski derivati in njihova uporaba | |
IL202474A0 (en) | 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof | |
SI2421864T1 (sl) | 1-pirazolo(4,3-c)izokinolinski derivati, njihova priprava in njihova terapevtska uporaba | |
IL226388A0 (en) | New indolizine derivatives, their preparation and medical use | |
EP2621490A4 (en) | PROPARGYL-TRIFLUOROMETHOXY-AMINO-BENZOTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF | |
IL220859A0 (en) | Alkyl-heterocycle-carbamate derivatives, their preparation and therapeutic application |